Tech Company Financing Transactions

Revision Optics Funding Round

Revision Optics closed a $25 million Series D funding round on 4/30/2007. Investors included Domain Associates, Canaan Partners and InterWest Partners.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Medical Devices & Instruments

Mailing Address

25651 Atlantic Ocean Dr. A1
Lake Forest, CA 92630
USA

Phone

(949) 707-2740

Website

www.revisionoptics.com

Email Address

[email protected]

Overview

The PRESBYLENS Corneal Inlay (CI) is a unique, patented refractive surgery solution that is designed to correct vision lost by the natural aging process called presbyopia.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

John Kilcoyne

        

Chief Financial Officer

Louis Bunn

        

VP - Operations

Joe Collins

        

VP - Regulatory Affairs

Michael Crompton

        

Browse more venture capital transactions:

Prev: 4/30/2007: Clone Interactive venture capital transaction
Next: 4/30/2007: InstaMed venture capital transaction

Share this article

Where The Data Comes From

We report on every notable VC transaction. VC investment data records reported here are sourced from company press releases and news coverage. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary